Literature DB >> 12893193

Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity.

Alex Lopata1, Franca Agresta, Michael A Quinn, Catherine Smith, Andrew G Ostor, Lois A Salamonsen.   

Abstract

OBJECTIVE: The known overexpression of matrix metalloproteinases (MMPs) by various tumors prompted a study to determine whether endometrial cancer could be detected by measuring MMPs in uterine cavity washings.
METHODS: The study populations comprised 95 women being treated for endometrial cancer and 98 women with other gynecological conditions. A simple method was developed for performing uterine lavage and preparing cell-free uterine supernatants for MMP analysis. Gelatin zymography revealed elevated levels of latent and active forms of MMP-2 and MMP-9 in patients with endometrial cancer. For each patient individual bands of gelatinase activity were scored from 0 to 5 and summed to provide a total MMP score for analysis.
RESULTS: The mean MMP score in uterine washings of patients with endometrial cancer was 10.0 (range 1 to 22) compared with 0.8 (range 0 to 15) in the group without this cancer (P < 0.001). Receiver operating characteristic analysis showed that an MMP cutoff score of 3 gave a sensitivity of 98% and specificity of 91% for detecting endometrial cancer. With this MMP cutoff, a positive result was 11 times as likely in endometrial cancer compared to other conditions. The mean MMP score in the group with nodal metastases (14.1) was significantly higher than that without nodal involvement (9.4, P = 0.005). MMP-9 but not MMP-2 was significantly associated with nodal metastasis (P = 0.01). There was no significant association between MMP score and histological grade of tumor, vascular invasion, or depth of myometrial invasion.
CONCLUSION: Gelatinase measurement in uterine washings was reliable for confirming the presence of endometrial cancer in the population studied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893193     DOI: 10.1016/s0090-8258(03)00328-7

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus.

Authors:  Xuan Zhang; Caitlin Healy; Warren B Nothnick
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 2.  Regulation of uterine matrix metalloproteinase-9 and the role of microRNAs.

Authors:  Warren B Nothnick
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

3.  Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma.

Authors:  Joanne Yap; Lois A Salamonsen; Tom Jobling; Peter K Nicholls; Evdokia Dimitriadis
Journal:  Reprod Biol Endocrinol       Date:  2010-06-17       Impact factor: 5.211

4.  Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.

Authors:  M Waheed Roomi; Tatiana Kalinovsky; Matthias Rath; Aleksandra Niedzwiecki
Journal:  Oncol Rep       Date:  2012-06-20       Impact factor: 3.906

5.  Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands.

Authors:  Oula Penate Medina; Merja Haikola; Marja Tahtinen; Ilkka Simpura; Sami Kaukinen; Heli Valtanen; Ying Zhu; Sari Kuosmanen; Wei Cao; Justus Reunanen; Tuula Nurminen; Per E J Saris; Peter Smith-Jones; Michelle Bradbury; Steven Larson; Kalevi Kairemo
Journal:  J Drug Deliv       Date:  2010-12-29

6.  Expression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significance.

Authors:  Evren Yilmaz; Meral Koyuncuoglu; Ilknur Bilkay Görken; Emre Okyay; Bahadir Saatli; Emine Cagnur Ulukus; Ugur Saygili
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

7.  Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.

Authors:  Navya Nair; Olga Camacho-Vanegas; Dmitry Rykunov; Matthew Dashkoff; Sandra Catalina Camacho; Cassie A Schumacher; Jonathan C Irish; Timothy T Harkins; Elijah Freeman; Isaac Garcia; Elena Pereira; Sviatoslav Kendall; Rachel Belfer; Tamara Kalir; Robert Sebra; Boris Reva; Peter Dottino; John A Martignetti
Journal:  PLoS Med       Date:  2016-12-27       Impact factor: 11.069

8.  A Specific Mixture of Nutrients Suppresses Ovarian Cancer A-2780 Tumor Incidence, Growth, and Metastasis to Lungs.

Authors:  Mohd Waheed Roomi; Tatiana Kalinovsky; Matthias Rath; Aleksandra Niedzwiecki
Journal:  Nutrients       Date:  2017-03-18       Impact factor: 5.717

9.  Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity.

Authors:  Noriko Yoshii; Toshio Hamatani; Noboru Inagaki; Takeshi Hosaka; Osamu Inoue; Mitsutoshi Yamada; Rei Machiya; Yasunori Yoshimura; Yasushi Odawara
Journal:  Reprod Biol Endocrinol       Date:  2013-05-11       Impact factor: 5.211

10.  Total PC Activity Is Increased in Uterine Lavage of Post-Menopausal Endometrial but Not Ovarian Cancer Patients.

Authors:  Sophea Heng; Andrew N Stephens; Tom W Jobling; Guiying Nie
Journal:  J Cancer       Date:  2016-08-12       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.